Navigation Links
International team gets new award to research the causes of bladder problems
Date:12/10/2007

common and highly distressing condition.

The BJU International Collaborative Research Award has been established by the peer-review journal, published by Wiley-Blackwell, to enable a university-based research unit in Great Britain or Ireland to collaborate formally with colleagues overseas.

We decided to award the grant to Professor Gillespie and Dr Van Koeveringe because we are confident that their research will progress the understanding and management of a medical condition that affects a large number of people worldwide, says Professor Christopher Woodhouse, Chairman of BJU International.

It is a subject that is of particular concern to urologists and one that has been shown to cause considerable distress, anxiety and reduced quality of life for the patients they see on a daily basis.

Two dozen projects met the stringent conditions and demanding criteria laid down by BJU International, with the winning bid chosen from a wide range of entries submitted from across Europe and the USA.


'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Blackwell Publishing Ltd.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... Carolina at Chapel Hill have managed to isolate a...s in Cystic Fibrosis. Blocking this// system allow... thus may herald in new treatments for the disease...isease caused by a defective gene that produces a ...
...though they do not develop zits, the do have oily ... to differentiate the cells// in the sebaceous gla...search examines how a sebaceous gland is formed. ...st 11 issue of Cell, Elaine Fuchs, a Howard Hughes...
...leptic son in July 2004 has for the first time spo...ess, Carmichael who is at the Brockville// Psychia...ories. "I wouldn't want any family to go through ...rry. I miss my son very much." Carmichael was a ph...
...st condom manufacturing unit in the country, is al...ncludes a vibrating ring plus a condom, a three-in...ceptive for women," said HLL chairman cum managing...porters here, Friday. Initially all these product...
Other Medicine News:Health News:Cellular System Causing Destruction Of Faulty Proteins In Cystic Fibrosis Identified 2Health News:'Blimp1' Gene Linked To Oily Skin 2
(Date:9/4/2008)... real-time PCR testing for the diagnostic ... Sept. 4 /- The U.S. Food & Drug,Admi...aqMan(R) HBV Test,the first assay for quantitatin...est uses Roche,s real-time PCR technology to quant...nt,s blood. Doctors may use viral load,testing res...
(Date:9/4/2008)...r 4 /- Axentis Pharma AG has,initiate...and tolerability,of a new therapeutic formulation ... cystic fibrosis patients. The new formulation all...ed directly to the site of,infection. The forthcom...ferent doses of the new drug. Initial results are ...
(Date:9/3/2008)...inhua--,Pharmaceutical comp...nced,that it has enrolled the first subject into i...g Bronchitol in cystic fibrosis sufferers., The P...ross North,America, Argentina and Germany, and is ...roval to market Bronchitol for cystic fibrosis in ...
(Date:9/3/2008)...Vascular Disease Awareness Month, CHARLOTTESVILLE...ticals,LLC, a clinical-stage drug-development comp... unmet medical needs, announced today that it has ...trial of its lead drug,candidate trans sodium croc...n the clinicaltrials.gov Website, is investigating...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Molecular glue with new effect 10629 1Molecular glue with new effect 10629 2Webcast Alert 3A HCA Announces 4Q Year End 07 Earnings Report 10628 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 2Healthcare Technologies Ltd Announces the Change of its Name to 22NexGen Biofuels Ltd 22 2902 1
... 14, 2007 /PRNewswire-FirstCall/ -- Shire plc ,th...t/Hyperactivity,Disorder (ADHD), announced that it...tment portfolio at the American Psychiatric,Associ... in San,Diego. , "The upcoming clinical research t... to understanding the science of ADHD treatment,",...
...NESS WIRE)--May 15, 2007 - Gemin X Biotechnologies...he journal Blood,demonstrated that its lead compou...tro in Mantle Cell Lymphoma (MCL) cell lines and,p...-070) is a small,molecule specifically designed to... family, a validated cancer target, thus restoring...
Other Medicine Technology:Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 3Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 4Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 5Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 6Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 7Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
...reference laboratory and a worldwide leader in inn...offers an extensive test menu of highly complex an...thology. Owned by the University of Utah, ARUP Lab...ation's university teaching hospitals and children...
Medicine Products: